| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 0.0 | 0.0 | 0.3 |
| Total income | 0.0 | 0.0 | 0.3 |
| Profit before exceptional items & tax | -0.1 | -0.1 | 0.0 |
| Profit before tax | -0.1 | -0.1 | 0.0 |
| Net profit | -0.1 | -0.1 | 0.0 |
| Operating margin | 0.0% | 0.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
Source
Read the filing ↗
BSE results filing, NSE: HINDBIO. Figures extracted from the filing.
Hindustan Bio Sciences Ltd: key numbers
- Share price
- ₹7.22
- Market cap
- ₹7.40 Cr
- Revenue (annual)
- ₹0.74 Cr
- Net profit (annual)
- ₹-0.08 Cr
- P/E (TTM)
- -35.9×Sector 50.4×
- Promoter holding
- 12.19%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hindustan Bio Sciences Ltd
All →
18:31 IST
BSE
Annual General Meeting
Hindustan Bio Sciences Annual General Meeting
Hindustan Bio Sciences Limited has issued a notice for its 34th Annual General Meeting to be held on September 30, 2026, in Hyderabad.
18:21 IST
BSE
Annual Report
Hindustan Bio Sciences Annual Report
Hindustan Bio Sciences Ltd submitted its 34th Annual Report for FY 2025-26, containing the AGM notice proposing a scheme of capital reduction.
18:51 IST
BSE
Financial Results
Hindustan Bio Sciences Q4 FY26 Results: Net Loss of ₹0.1 Cr
Hindustan Bio Sciences Ltd reported a net loss of ₹0.1 Cr for Q4 FY26.
- Key figure
- Net loss ₹0.1 Cr